Hydrogenology
Hydrogenology editorial study record

The Role of Hyperthermia in Methamphetamine-Induced Depression-Like Behaviors: Protective Effects of Coral Calcium Hydride.

Wang X, Tong B, Hui R, Hou C, Zhang Z, Zhang L, Xie B, Ni Z, Cong B, Ma C, Wen D. · Frontiers in Molecular Neuroscience. 2021;14:808807.

PreclinicalOther formsPublished 2021
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled mouse experiments

Research topic

Sleep and mood research

Administration classification

Other forms

Study result signal

Mixed positive preclinical signal.

Outcome type

Animal functional behavior and biomarker outcomes.

Reported in the source

Methods at a glance

Population or model

Male mice in methamphetamine hyperthermia and depression-like behavior models.

Sample

390 mice distributed across multiple experiments.

Duration

Acute and repeated schedules varied by experiment.

Intervention

Coral calcium hydride, 100 or 200 mg/kg by gavage, before or after methamphetamine depending on experiment.

Hydrogen form

Hydrogen generated from coral calcium hydride; not Brown's gas.

H₂ specification

The product combines coral calcium and hydrogen generation; the article included coral-calcium controls in selected experiments.

H₂ flow

Not applicable — gavage.

O₂ delivered with H₂

No oxygen was co-delivered.

Comparator

Vehicle, methamphetamine and coral-calcium controls as reported by experiment.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Body temperature, tail-suspension and forced-swim behavior, locomotion and molecular markers.

Reported result

The higher dose affected hyperthermia and both tested doses affected selected depression-like behavior measures; locomotion was not improved.

Results-extraction completeness

The full article, all experimental methods, behavioral outcomes and null locomotor finding were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Preclinical behavioral models do not establish an antidepressant effect in people; product components and hydrogen generation are not fully separable.

Applies directly to

The reported methamphetamine mouse models.

Preliminary appraisal framework

SYRCLE animal-study tool — preliminary

Preliminary risk-of-bias status

Some concerns

Appraisal rationale

Many experiments were reported, but concealment and outcome-assessor blinding were not consistently established.

Appraisal domains

Randomization/allocation reporting is limited · Blinding of personnel is unclear · Attrition is incompletely reported in places · Blinding of outcome assessors is unclear · No prospectively registered analysis plan identified

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 35058751 · DOI: 10.3389/fnmol.2021.808807

Publisher access

Free full article in PubMed Central.

Extraction basis

PubMed record and PubMed Central full text; extraction checked 9 August 2026.

Record revision

2026-08-10